- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.04. | HAMLET BIOPHARMA AB: New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer | 1 | Cision News | ||
| 08.04. | HAMLET BIOPHARMA AB: New discoveries in infection biology, highlighting the rich potential of non-antibiotic treatments of infections | 2 | Cision News | ||
| HAMLET BIOPHARMA Aktie jetzt für 0€ handeln | |||||
| 07.04. | HAMLET BIOPHARMA AB: New granted patents added to Hamlet BioPharma's extensive patent portfolio in cancer and infection | 2 | Cision News | ||
| 07.04. | HAMLET BIOPHARMA AB: Strong Alpha1H treatment effects confirmed in patients with bladder cancer, in final analysis. Clinical study report is being completed for submission to the FDA | 1 | Cision News | ||
| 20.02. | HAMLET BIOPHARMA AB: The board of Hamlet BioPharma proposes licensing agreement with Linnane Pharma, which creates conditions for an effective commercialization of Bamlet and positive value for both companies | 2 | Cision News | ||
| 19.02. | HAMLET BIOPHARMA AB: Elisabeth Parker appointed as Business development expert in Hamlet BioPharma and joins the team on March 3rd | 1 | Cision News | ||
| 18.02. | HAMLET BIOPHARMA AB: Catharina Svanborg appointed as CEO and assumes the position immediately, board member Magnus Nylén acting Chairman | 1 | Cision News | ||
| 13.02. | HAMLET BIOPHARMA AB: Q2 Interim Report October 2024 - December 2024 | 2 | Cision News | ||
| 10.01. | HAMLET BIOPHARMA AB: Invitation to monthly digital events and presentations of quarterly report | 1 | Cision News | ||
| 28.11.24 | HAMLET BIOPHARMA AB: Hamlet BioPharma Participates in Økonomisk Ugebrev's Life Science Investor Konference 2024 | 1 | Cision News | ||
| 19.11.24 | HAMLET BIOPHARMA AB: Hamlet BioPharma Participates in the BioStock Life Science Summit 2024 | 2 | Cision News | ||
| 15.11.24 | HAMLET BIOPHARMA AB: Q1 Interim Report July 2024 - September 2024 | 1 | Cision News | ||
| 04.11.24 | HAMLET BIOPHARMA AB: Hamlet BioPharma will present at the BioStock Life Science Summit, November 20 | 1 | Cision News | ||
| 04.11.24 | HAMLET BIOPHARMA AB: Two in-depth features about Hamlet BioPharma in the prestigious CEO world magazines and pulse 2.0 business news website | 1 | Cision News | ||
| 30.10.24 | Hamlet BioPharma: Interview With Chairman Professor Catharina Svanborg About The Cancer Treatment & Infections Research Company | 1 | pulse2.com |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 51,88 | -8,68 % | Novo Nordisk: Überraschende Verkaufsempfehlung | Zur Wochenmitte befindet sich die Aktie von Novo Nordisk erneut auf dem absteigenden Ast. Zur Stunde verliert das Papier gut ein Prozent an Wert. Auf die Stimmung drückt eine Verkaufsempfehlung. Die... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,138 | +3,38 % | TAAT Global Alternatives Inc (2): TAAT Global has no material changes |
Das Unternehmen HAMLET BIOPHARMA AB kann der Branche Pharma zugeordnet werden. Der aktuelle Kurs liegt bei 0,357 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HAMLET BIOPHARMA AB finden Sie auf Wallstreet Online.
